Parkinson's Disease Registry of the Muhammad Ali Parkinson Center

Parkinson's Disease Clinical Trial

Official title:

Parkinson's Disease Registry

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00217321
• Other study ID #: 03BN117
• Status: Active, not recruiting
• Phase: N/A
• First received: September 15, 2005
• Last updated: July 20, 2010
• Start date: November 2003
• Est. completion date: December 2015

Study information

• Verified date: September 2006
• Source: Muhammad Ali Parkinson Research Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of the Parkinson's disease Registry is to develop a national and international database of persons with Parkinson's disease (PD). The Registry will be used to facilitate the development of new therapies and healthcare services to improve the quality of life for people with PD. It will also be a means for investigators in the field of PD to quickly identify and notify subjects about other research studies for which they are eligible.

Objectives include:

• Assess current treatment approaches and develop best-practice guidelines

• Track the functional abilities, access to healthcare and cost of illness of people with PD over time

• Drive the development of innovative research projects

• Accelerate the process of informing patients of research projects for which they may be eligible

Description:

What do you need to know?

• Any individual diagnosed with PD is eligible to enroll.

• Participation in the registry is voluntary, confidential and free of charge.

• Eligible participants will be notified about opportunities to participate in clinical trials, though they are under no obligation to enter.

• Participants will need to complete an updated questionnaire every six months.

• Participants may also be asked to complete additional surveys for PD research projects.

• Any data provided will be used in scientific publications in summary form only.

• Participant names will not be released to anyone outside the Parkinson's disease Registry management team without written authorization, nor will names be sold for advertising or fund-raising purposes.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 20000
• Est. completion date: December 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Clinical diagnosis of Parkinson's disease

Exclusion Criteria:

• No clinical diagnosis of Parkinson's disease

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective

Related Conditions & MeSH terms

• Parkinson Disease
• Parkinson's Disease

Locations

Country	Name	City	State
United States	Muhammad Ali Parkinson Research Center	Phoenix	Arizona

Sponsors (2)

Lead Sponsor	Collaborator
Muhammad Ali Parkinson Research Center	Barrow Neurological Foundation

Country where clinical trial is conducted

United States,